Background: Clinical infections caused by multidrug-resistant pathogenic bacteria are associated with increased morbidity and mortality, imposing a severe economic burden. Pseudomonas aeruginosa, a gram-negative bacterium, had demonstrated a prominent level of acquired antimicrobial resistance to its selective antimicrobials. Currently, there is no updated information about the antimicrobial susceptibility pattern of Pseudomonas aeruginosa in Grenada. Hence, the present study aimed to determine the antimicrobial susceptibility pattern of P. aeruginosa from the clinical isolates of dogs in Grenada. 
 
Methods: This retrospective study used the diagnostic reports from January 2015 to December 2022. The diagnostic microbiology laboratory reports of canine patients at the Small Animal Clinic of St. George&rsquo;s University in Grenada were analyzed to study the antimicrobial susceptibility pattern of P. aeruginosa. 
 
Result: Among the various bacterial clinical isolates, ninety-one clinical samples were positive for P. aeruginosa. The antimicrobial susceptibility test pattern of these isolates revealed susceptibility to gentamicin (95.6 %), ceftazidime (96.7%), imipenem (97.7%) and ciprofloxacin (97.8%). The result of the present retrospective study illustrates that P. aeruginosa isolates from canine patients in Grenada are susceptible to the recommended antimicrobial drugs. However, this study also revealed the recent development of progressive antimicrobial resistance. This mandates the judicious use of antibacterial drugs against bacterial infections in Grenada.

Retrospective Analysis of Antimicrobial Susceptibility Pattern of Pseudomonas aeruginosa from Clinical Samples of Dogs in Grenada, West Indies